External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer

Metastatic pattern in colorectal cancer is strongly influenced by histological subtype

(2014) N. Hugen et al.   ANNALS OF ONCOLOGY

Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review

(2014) D A M Sloothaak et al.   BRITISH JOURNAL OF CANCER

Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer

(2014) J. Segelman et al.   Colorectal Disease

Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases

(2014) P. Sammartino et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer

(2013) Y.R.B.M. van Gestel et al.   EJSO

pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited

(2013) P. Snaebjornsson et al.   INTERNATIONAL JOURNAL OF CANCER

Patients at Risk for Peritoneal Surface Malignancy of Colorectal Cancer Origin: The Role of Second Look Laparotomy

(2013) Björn LDM Brücher et al.   Journal of Cancer

Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

(2012) J. Segelman et al.   BRITISH JOURNAL OF SURGERY